(Q82350688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Yuji Toiyama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Chikao Miki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yasuhiro Inoue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sayaka Minobe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hiroko Urano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Masato Kusunoki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

29 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

46-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

Interleukin-10 and Gp130 cytokines in human multiple myeloma

15 January 2020

cites work

1 reference

12 December 2020

Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration.

1 reference

12 December 2020

Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome

1 reference

12 December 2020

Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.

1 reference

12 December 2020

Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop.

1 reference

12 December 2020

Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells

1 reference

12 December 2020

Leptin and the immunosuppression of malnutrition.

1 reference

12 December 2020

Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma

1 reference

12 December 2020

Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease

1 reference

12 December 2020

Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism

1 reference

12 December 2020

Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery

1 reference

12 December 2020

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.

1 reference

12 December 2020

Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience

1 reference

12 December 2020

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

12 December 2020

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

12 December 2020

Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10.

1 reference

12 December 2020

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

12 December 2020

IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor

1 reference

12 December 2020

Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice

1 reference

12 December 2020

Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers

1 reference

12 December 2020

A review of the association between interleukin-10 and human B-cell malignancies

1 reference

12 December 2020

Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants

1 reference

12 December 2020

Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice

1 reference

12 December 2020

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

1 reference

12 December 2020

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

1 reference

12 December 2020

Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response

1 reference

12 December 2020

Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients

1 reference

12 December 2020

Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide

1 reference

12 December 2020

Persistence of epidermal growth factor receptor and interleukin 10 in blood of colorectal cancer patients after surgery identifies patients with high risk to relapse.

1 reference

12 December 2020

Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6.

1 reference

12 December 2020

Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection

1 reference

12 December 2020

Perioperative host-tumor inflammatory interactions: a potential trigger for disease recurrence following a curative resection for colorectal cancer

1 reference

12 December 2020

Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies

1 reference

12 December 2020

Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

1 reference

12 December 2020

Interleukin-10 therapy--review of a new approach

1 reference

12 December 2020

Human interleukin-10 can directly inhibit T-cell growth

1 reference

12 December 2020

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers

1 reference

12 December 2020

Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease

1 reference

12 December 2020

Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis

1 reference

12 December 2020

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma

1 reference

12 December 2020

Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma

1 reference

12 December 2020

T cells and aging, January 2002 update.

1 reference

12 December 2020

Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma

1 reference

12 December 2020

IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response

1 reference

12 December 2020

10.1007/S00595-009-4016-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037839%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference